Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Xencor Inc | Director | Common Stock | 8.49K | $176K | $20.68 | Sep 27, 2024 | Direct |
Xencor Inc | Director | Stock Option (Right to Buy) | 12K | Jun 13, 2024 | Direct | ||
INTERCEPT PHARMACEUTICALS, INC. | Director | Common Stock | 0 | $19.00 | Nov 8, 2023 | Direct | |
INTERCEPT PHARMACEUTICALS, INC. | Director | Option to Purchase Common Stock | 0 | Nov 8, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XNCR | Xencor Inc | Sep 27, 2024 | 1 | -$51.8K | 4 | Oct 1, 2024 | Director |
XNCR | Xencor Inc | Jun 13, 2024 | 2 | $0 | 4 | Jun 17, 2024 | Director |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | Nov 8, 2023 | 5 | -$501K | 4 | Nov 13, 2023 | Director |
XNCR | Xencor Inc | Jun 20, 2023 | 2 | $0 | 4 | Jun 22, 2023 | Director |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | May 24, 2023 | 2 | $0 | 4 | May 25, 2023 | Director |
XNCR | Xencor Inc | Jun 23, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | May 25, 2022 | 2 | $0 | 4 | May 27, 2022 | Director |
XNCR | Xencor Inc | Jun 24, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Director |
ICPT | INTERCEPT PHARMACEUTICALS, INC. | May 27, 2021 | 2 | $0 | 4 | Jun 1, 2021 | Director |